ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag hiv pathogenesis disease medicine microbiology

Microscope image of A549-ACE2 lung cells coinfected with SARS-CoV-2 and a reporter vector containing a key regulatory variant of interest in the region on human chromosome 3
How Genes from Neanderthals Predispose People to Severe COVID-19
Alakananda Dasgupta | Feb 22, 2023 | 4 min read
Researchers dissect the Neanderthal-derived region on chromosome 3 that drives severe COVID-19 to zero in on the key causal variants.
The Vaginal Microbiome is Finally Getting Recognized
Hannah Thomasy, PhD, Drug Discovery News | Sep 25, 2023 | 10+ min read
Vaginal dysbiosis has long been a taboo subject, but studying and optimizing the vaginal microbiome could be a game changer for women's health.
SIV and the Expanding Virome
Sabrina Richards | Oct 10, 2012 | 3 min read
Monkeys infected with simian immunodeficiency virus have a higher diversity of gut viruses, pointing to a possible role of the virome in SIV pathogenesis.
Stem cells: home of HIV?
Jef Akst | Mar 6, 2010 | 3 min read
Human immunodeficiency virus (HIV) can infect bone marrow cells -- including, possibly, hematopoietic stem cells, according to a study published online today (March 7) in Nature Medicine. Human Immunodeficiency VirusImage: Wikimedia commons, NIAIDThe findings suggest the virus can hide in an inactive state for long periods of time, evading treatment, even in individuals without detectable viral loads. "It's a little bit surprising to see that [HIV infects] progenitor cells, and [possibly] ste
The AIDS Research Evaluators
Lynn Gambale | Jul 9, 1995 | 6 min read
Chairman: Arnold Levine, chairman, department of molecular biology, Princeton University Barry Bloom, Weinstock Professor and Howard Hughes Medical Institute (HHMI) investigator, department of microbiology and immunology, Albert Einstein College of Medicine, New York Rebecca Buckley, professor of pediatrics and immunology, Duke University Medical Center Charles Carpenter, chairman, Office of AIDS Research Advisory Committee; professor of medicine,Brown University School of Medicine Don
Humanized Mouse Models: Applications in Oncology and Infectious Disease
The Scientist Marketing Team | Aug 10, 2015 | 1 min read
In this webinar, our panel of experts will discuss the successes and caveats of using humanized mouse models to understand disease biology and evaluate therapeutic strategies. 
Mounting Threat Of Infectious Diseases Contributes To Rising Need For Immunology Research Specialists
Marcia Clemmitt | Mar 21, 1993 | 10 min read
In today's otherwise sluggish biomedical job market, career prospects for these scientists are improving in academia as well as industry Immunology research is riding the crest of a wave, with significant laboratory results proliferating, observers of the field say. "Immunology remains one area in biomedicine that has relatively good prospectives for employment, and one that is likely to continue doing somewhat better than most others," says Robert Rich, a professor of microbiology, immuno
Psychoactive Drugs and Infectious Diseases
A. J. S. Rayl | Apr 16, 2000 | 10+ min read
For nearly a century, it's been known that drugs of abuse alter the immune system. Since the outbreak of the AIDS epidemic in the early 1980s, however, an explosion of data has given rise to a rapidly evolving area of research. Investigators around the world have shown that such psychoactive drugs as heroin, morphine, cocaine, and marijuana affect both the neurophysiologic and immunologic systems. In recent years, researchers have produced strong experimental evidence that these drugs of a
Middle aged man with glasses wearing a blue shirt and tan blazer with a red paisley tie looking into the camera
Immunologist Thomas Hodge Dies of COVID-19 at 69
Lisa Winter | Aug 30, 2021 | 2 min read
A former academic and consultant, Hodge cofounded the CrisiScience Collective to help combat the pandemic.
Bioterrorism Research: New Money, New Anxieties
John Dudley Miller | Apr 6, 2003 | 8 min read
Ned Shaw US scientists have reason to feel both heady and scared. The federal government recently released unprecedented billions of dollars to fund bioterrorism research. Yet, the merits of this sudden shift in focus are being debated, and some worry that the money will be squandered or wasted. "I have been really very upset by the focus on bioterrorism," says Stanley Falkow, professor of microbiology and immunology and of medicine at Stanford University. "Everybody's talking about it, but th

Run a Search

ADVERTISEMENT